pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'nsclc', 'pembro', 'sclc', 'keynote-671']
keynote-671: efs benefit with neoadjuvant pembro plus chemo followed by resection and adjuvant pembro in early-stage nsclc #asco23 
Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition